FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to novel compounds of formula I, as well as pharmaceutical compositions based thereon.
(formula I).
EFFECT: obtaining novel compounds which can be used as RORγ inhibitors, suitable for treating RORγ-mediated diseases or conditions.
20 cl, 47 ex
Title | Year | Author | Number |
---|---|---|---|
ROR GAMMA (RORγ) MODULATORS | 2016 |
|
RU2727698C2 |
ROR GAMMA MODULATORS (RORΓ) | 2016 |
|
RU2733406C2 |
ROR GAMMA (RORγ) MODULATORS | 2016 |
|
RU2727191C2 |
ROR GAMMA MODULATORS (RORγ) | 2016 |
|
RU2735546C2 |
4-PHENYL-5-OXO-1, 4, 5, 6, 7, 8-HEXAHYDROCHINOLINE DERIVATIVES AS MEDICATIONS FOR TREATMENT OF INFERTILITY | 2006 |
|
RU2403243C2 |
POLY(ADP-RIBOSO)POLYMERASE INHIBITORS | 2007 |
|
RU2455286C2 |
PYRROLE DERIVATIVES AS MEDICINAL SUBSTANCES | 2005 |
|
RU2470916C2 |
DERIVATIVES OF 2-AMINOPIRIDINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND INTERMEDIATE SUBSTANCES | 1999 |
|
RU2226527C2 |
DERIVATIVES OF BICYCLIC IMINOACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | 2004 |
|
RU2335494C2 |
SPIROOXYINDOLE DERIVATIVES AND APPLICATION THEREOF AS THERAPEUTIC AGENTS | 2006 |
|
RU2415143C2 |
Authors
Dates
2020-08-24—Published
2016-06-03—Filed